BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 834123)

  • 1. Maximum lipid reduction by partial ileal bypass: a test of the lipid-atherosclerosis hypothesis.
    Buchwald H; Moore RB; Varco RL
    Lipids; 1977 Jan; 12(1):53-8. PubMed ID: 834123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Program on the Surgical Control of the Hyperlipidemias: a status report.
    Buchwald H; Moore RB; Matts JP; Long JM; Varco RL; Campbell GS; Pearce MB; Yellin AE; Blankenhorn DH; Holmes WL; Smink RD; Sawin HS
    Surgery; 1982 Oct; 92(4):654-62. PubMed ID: 6750834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Campos CT; Boen JR; Nguyen PA; Williams SE
    J Am Coll Cardiol; 1995 Aug; 26(2):351-7. PubMed ID: 7608434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical intervention in atherosclerosis: partial ileal bypass and the Program on Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Fitch L; Varco RL
    Pharmacol Ther; 1985; 29(1):93-109. PubMed ID: 3914647
    [No Abstract]   [Full Text] [Related]  

  • 5. The partial ileal bypass operation in treatment of the hyperlipidemias.
    Buchwald H; Moore RB; Varco RL
    Adv Exp Med Biol; 1975; 63():221-30. PubMed ID: 1199864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten years clinical experience with partial ileal bypass in management of the hyperlipidemias.
    Buchwald H; Moore RB; Varco RL
    Ann Surg; 1974 Oct; 180(4):384-92. PubMed ID: 4416064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Varco RL; Matts JP; Long JM; Fitch LL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    N Engl J Med; 1990 Oct; 323(14):946-55. PubMed ID: 2205799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Program on the surgical control of the hyperlipidemias: 1994 report.
    Buchwald H; Campos CT
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S3-10. PubMed ID: 8907208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of heterozygous type II hyperlipidemia by partial ileal bypass in a pediatric population.
    Schwartz MZ; Varco RL; Buchwald H
    J Pediatr Surg; 1976 Jun; 11(3):411-8. PubMed ID: 182951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical angiographic regression of atherosclerosis after partial ileal bypass.
    Buchwald H; Moore RB; Rucker RD; Amplatz K; Castaneda WR; Francoz RA; Pasternak RC; Varco RL
    Atherosclerosis; 1983 Jan; 46(1):117-28. PubMed ID: 6838688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH Group.
    Buchwald H; Matts JP; Fitch LL; Varco RL; Campbell GS; Pearce M; Yellin A; Smink RD; Sawin HS; Campos CT
    J Clin Epidemiol; 1989; 42(12):1111-27. PubMed ID: 2685177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term results of the use of different modifications of the partial ileal shunt operation in the treatment of patients with atherogenic dyslipoproteinemias].
    Mirchuk KK; Lebedev LV; Sedletskiĭ IuI
    Vestn Khir Im I I Grek; 2001; 160(1):29-32. PubMed ID: 11258320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial ileal bypass for hypercholesterolemia. 20- to 26-year follow-up of the first 57 consecutive cases.
    Buchwald H; Stoller DK; Campos CT; Matts JP; Varco RL
    Ann Surg; 1990 Sep; 212(3):318-29; discussion 329-31. PubMed ID: 2396883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial ileal bypass inhibits atherosclerosis in WHHL rabbits.
    Van Niekerk JL; Demacker PN; Hendriks T; De Boer HH
    Atherosclerosis; 1983 Sep; 48(3):243-52. PubMed ID: 6639706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of the therapeutic effects of ileal bypass in dogs with experimentally established hypercholesterolemia and atherosclerosis.
    Frost JW; Finch WT; Younger RK; Butts WH; Scott HW
    Surg Forum; 1970; 21():398-9. PubMed ID: 5514777
    [No Abstract]   [Full Text] [Related]  

  • 17. Five years experience with the use of partial ileal bypass in the treatment of hypercholesterolemia and atherosclerosis.
    Buchwald H; Moore RB; Lee GB; Baltaxe H; Amplatz K; Frantz ID; Varco RL
    Isr J Med Sci; 1969; 5(4):760-5. PubMed ID: 5820512
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of total and low-density lipoprotein cholesterol change after partial ileal bypass.
    Campos CT; Matts JP; Santilli SM; Fitch LL; Long JM; Speech JC; Buchwald H
    Am J Surg; 1988 Jan; 155(1):138-46. PubMed ID: 3341527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits.
    Tijerina O; Dombrovskis S; Esper E; Matts JP; Campos CT; Buchwald H
    Surgery; 1988 Oct; 104(4):796-805. PubMed ID: 3175875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study on serum lipids and atherosclerotic plaque formation in diet-induced and familial hypercholesterolemia in rabbits, and the effect of partial ileal bypass.
    van Niekerk JL; Demacker PN; Hendriks T; de Boer HH
    Artery; 1985; 12(4):263-76. PubMed ID: 4074136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.